BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
LifeMD, Inc.'s (NASDAQ:LFMD) Top Owners Are Retail Investors With 45% Stake, While 38% Is Held by Institutions
B.Riley Financial Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $11
LifeMD, Inc. 8.875% CUM PFD A Declares $0.5547 Dividend
Press Release: LifeMD(R) Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Express News | LifeMD Announces Major Enhancements to Its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
Express News | Shares of Teladoc Health Down 1.7%, LifeMD Down 4.7%, Hims & Hers Health Down 5.8%
Express News | Shares of Telehealth Firms Fall After Eli Lilly Launches Single-Dose Vials of Weight-Loss Drug
Pfizer Launches Direct Sales Website for Common Vaccines, Medicines
LifeMD to Participate in Three Investor Conferences During September
B.Riley Financial Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $11
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD)
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 27% Cheaper
Analyst Estimates: Here's What Brokers Think Of LifeMD, Inc. (NASDAQ:LFMD) After Its Second-Quarter Report
Express News | Cantor Fitzgerald Reiterates Overweight on LifeMD, Maintains $15 Price Target
LifeMD Analyst Ratings
LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript
Insider Stock Buying Of LifeMD Delivers Return On US$501.0k Investment
B. Riley Trims Price Target on LifeMD to $11 From $12, Maintains Buy Rating